# Esophageal Pressure-Guided Optimal PEEP/mPaw in CMV and HFOV: The EPOCH Study

> **NCT02342756** · NA · UNKNOWN · sponsor: **University of Toronto** · enrollment: 20 (estimated)

## Conditions studied

- Respiratory Distress Syndrome, Adult
- Ventilator-Induced Lung Injury

## Interventions

- **DEVICE:** Targeting transpulmonary pressure to avoid VILI

## Key facts

- **NCT ID:** NCT02342756
- **Lead sponsor:** University of Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2015-01-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02342756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02342756, "Esophageal Pressure-Guided Optimal PEEP/mPaw in CMV and HFOV: The EPOCH Study". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02342756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*